Patricia Moorman

Professor

Duke University
Country flagUnited States
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (2)

Background: Menstrual cycle characteristics—including age at menarche and cycle length— have been associated with ovarian cancer risk in White women. However, the associations between menstrual cycle characteristics and ovarian cancer risk among Black women have been sparsely studied. Methods: Using the Ovarian Cancer in Women of African Ancestry (OCWAA) Consortium that includes 1,024 Black and 2,910 White women diagnosed with epithelial ovarian cancer (EOC) and 2,325 Black and 7,549 White matched controls, we investigated associations between menstrual cycle characteristics (age at menarche, age at menstrual regularity, cycle length, and ever missing three periods) and EOC risk by race and menopausal status. Multivariable logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals (CI). Results: Black women were more likely to be Conclusions: Earlier age at menarche and cycle irregularity are associated with increased EOC risk for White but not Black women. Impact: Associations between menstrual cycle characteristics and EOC risk were not uniform by race.

Year:

2025

Background: Tumor-infiltrating lymphocytes (TIL) confer a survival benefit among patients with ovarian cancer; however, little work has been conducted in racially diverse cohorts. Methods: The current study investigated racial differences in the tumor immune landscape and survival of age- and stage-matched non-Hispanic Black and non-Hispanic White women with high-grade serous ovarian carcinoma (HGSOC) enrolled in two population-based studies ( n = 121 in each racial group). We measured TILs (CD3 + ), cytotoxic T cells (CD3 + CD8 + ), regulatory T cells (CD3 + FoxP3 + ), myeloid cells (CD11b + ), and neutrophils (CD11b + CD15 + ) via multiplex immunofluorescence. Multivariable Cox proportional hazard regression was used to estimate the association between immune cell abundance and survival overall and by race. Results: Overall, higher levels of TILs, cytotoxic T cells, myeloid cells, and neutrophils were associated with better survival in the intratumoral and peritumoral region, irrespective of tissue compartment (tumor, stroma). Improved survival was noted for T-regulatory cells in the peritumoral region and in the stroma of the intratumoral region, but no association for intratumoral T-regulatory cells. Despite similar abundance of immune cells across racial groups, associations with survival among non-Hispanic White women were consistent with the overall findings, but among non-Hispanic Black women, most associations were attenuated and not statistically significant. Conclusions: Our results add to the existing evidence that a robust immune infiltrate confers a survival advantage among women with HGSOC; however, non-Hispanic Black women may not experience the same survival benefit as non-Hispanic White women with HGSOC. Impact: This study contributes to our understanding of the immunoepidemiology of HGSOC in diverse populations.

Year:

2025

Collaborators (14)

Lynn Rosenberg

Boston University

UNITED STATES
View details

Edward Peters

Professor and Chair

University of Nebraska College of Public Health

UNITED STATES
View details

Heather M Ochs-Balcom

Professor & Associate Chair

University at Buffalo

UNITED STATES
View details

Joellen Schilkdraut

Professor

Emory University

UNITED STATES
View details

Kristin Guertin

Assistant Professor

University of Connecticut

UNITED STATES
View details

Evan Myers

Duke University

UNITED STATES
View details

Ann G. Schwartz

Wayne State University School of Medicine

UNITED STATES
View details

Jose Conejo-Garcia

Duke Science and Technology Scholar

Duke Medicine

UNITED STATES
View details

Anna H. Wu

Professor

University of Southern California

UNITED STATES
View details

Michele L. Cote

Indiana University

UNITED STATES
View details

Jennifer Anne Doherty

Professor

University of Utah

UNITED STATES
View details

Veronica Setiawan

Associate Professor

University of Southern California

UNITED STATES
View details

Elisa Bandera

Chief

Rutgers Cancer Institute of New Jersey

UNITED STATES
View details

Charlotte Joslin

University of Illinois Chicago (UIC)

UNITED STATES
View details